Assoc Prof Dr Reham Abdel-Kader | protection Alzheiemer’s disease | Best Researcher Award

Head of Pharmacology and Toxicology department at German University in Cairo , Egypt

Dr. Reham Mahmoud Abdel-Kader is an accomplished academic and researcher currently serving as the Head of the Pharmacology and Toxicology Department at the German University in Cairo (GUC). With extensive experience in pharmacology, she leads significant research initiatives and manages a diverse team of faculty members, guiding them in both teaching and research activities.

Profile

google scholar

🎓 Education

• Ph.D. in Pharmacology (magna cum laude)
  Institute of Pharmacology, Johann Wolfgang Goethe University, Frankfurt, Germany (2009)
• B.Sc. in Pharmacy
  Faculty of Pharmacy, Cairo University, Egypt (2001)
• IGCSE
  Dar El Tarbiah School, Egypt (1996)

Professional Experience

• Head of Pharmacology and Toxicology Department, German University in Cairo (GUC) (Sept 2022 – Present)
  Managing a large department with significant responsibilities in teaching, research, and faculty representation.
• Head of Pharmacology, Toxicology and Clinical Pharmacy Department, GUC (Jun 2019 – Sept 2022)
  Oversaw departmental operations, course implementation, and research groups focusing on Alzheimer’s and breast cancer.
• Associate Professor, Department of Pharmacology, Toxicology and Clinical Pharmacy, GUC (Oct 2018 – Present)
  Engaged in teaching, research supervision, and curriculum development.
• Lecturer of Pharmacology, GUC (Mar 2010 – Sept 2018)
  Delivered lectures and supervised various graduate research projects.
• Member and Head of Internal Auditing Committee, GUC (2013 – Present)
  Ensured compliance and quality standards across the pharmacy and biotechnology faculties.

Research Interests

Dr. Abdel-Kader’s research focuses on:

• Neuropharmacology, particularly in the context of Alzheimer’s disease and mitochondrial dysfunction.
• Investigating the role of mitochondria in cancer biology, particularly in triple-negative breast cancer.
• Enhancing mitochondrial biogenesis as a therapeutic approach for neurodegenerative diseases.
• Development of novel pharmacological interventions using natural products.

🏆 Awards

• Fully funded Joint Swiss-Egyptian project (SPIRIT) by the Swiss National Science Foundation (2021-2024)
• STDF Basic and Applied Research Grant for Alzheimer’s treatment approach (2021-2024)
• DAAD-BMBF Funding for autism research comparing Egyptian and European patients (2020-2022)

📝 Publications Top Notes :

protection Alzheiemer’s disease

1. Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer (2024) – Cancer Cell Internationa
2. Role of cystathionine β-synthase and 3-mercaptopyruvate sulfurtransferase in the regulation of proliferation, migration, and bioenergetics of murine breast cancer cells (2023) – Antioxidants
3. Origanum majorana L. protects against neuroinflammation-mediated cognitive impairment: a phyto-pharmacological study (2023) – BMC Complementary Medicine and Therapies
4. Enhancement of mitochondrial function using NO releasing nanoparticles; a potential approach for therapy of Alzheimer’s disease (2023) – European Journal of Pharmaceutics and Biopharmaceutics
5. Neuromodulatory Activity of Dietary Phenolics Derived from Corchorus olitorius L. (2019) – Journal of Food Science
6. The effect of Pyrroloquinoline quinone and Resveratrol on the Survival and Regeneration of Cerebellar Granular Neurons (2019) – Neuroscience Letters
7. Enhancement of cognitive functions by rice bran extract in a neuroinflammatory mouse model via regulation of PPARγ (2018) – Journal of Functional Foods
8. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer’s Disease Mouse Model (2016) – Molecular Neurobiology